Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionDNA translocase activity

FBH1 ATRX

4.94e-055452GO:0015616
GeneOntologyCellularComponentcell leading edge

VIL1 ADGRE2 KCNC2 IQGAP2 INPP5K SYNE2 KPTN

1.02e-04500467GO:0031252
DomainGPS

ADGRE2 ADGRE3

3.17e-0334462SM00303
DomainGPCR_2_secretin-like_CS

ADGRE2 ADGRE3

3.17e-0334462IPR017983
DomainGPS

ADGRE2 ADGRE3

3.35e-0335462PF01825
DomainGPS

ADGRE2 ADGRE3

3.54e-0336462PS50221
DomainGPS

ADGRE2 ADGRE3

3.74e-0337462IPR000203
DomainG_PROTEIN_RECEP_F2_2

ADGRE2 ADGRE3

6.74e-0350462PS00650
Domain7tm_2

ADGRE2 ADGRE3

6.74e-0350462PF00002
DomainGPCR_2-like

ADGRE2 ADGRE3

9.59e-0360462IPR017981
DomainGPCR_2_secretin-like

ADGRE2 ADGRE3

9.59e-0360462IPR000832
DomainG_PROTEIN_RECEP_F2_4

ADGRE2 ADGRE3

9.90e-0361462PS50261
DomainCH

IQGAP2 SYNE2

1.12e-0265462SM00033
Pubmed

ATP-releasing SWELL1 channel in spinal microglia contributes to neuropathic pain.

LRRC8A CX3CR1

1.71e-06246236989353
Pubmed

PHDs/CPT1B/VDAC1 axis regulates long-chain fatty acid oxidation in cardiomyocytes.

EGLN3 CPT1B

1.03e-05446234610308
Pubmed

The EGF-TM7 family: a postgenomic view.

ADGRE2 ADGRE3

2.56e-05646214647991
Pubmed

The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse.

ADPRH ART4

6.12e-05946212070318
Pubmed

EGLN3 inhibition of NF-κB is mediated by prolyl hydroxylase-independent inhibition of IκB kinase γ ubiquitination.

EGLN3 RNF31

9.34e-051146223732909
Pubmed

Scanning the human proteome for calmodulin-binding proteins.

ATRX SLF2 SYNE2

2.50e-049246315840729
Pubmed

Interactome mapping suggests new mechanistic details underlying Alzheimer's disease.

PSEN2 RNF31 ANKH

4.35e-0411146321163940
Pubmed

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.

LRRC8A DGLUCY SPG11 PSEN2 SLC16A4 CTDNEP1 COG7

4.57e-04106146733845483
Pubmed

Mapping a dynamic innate immunity protein interaction network regulating type I interferon production.

RNF31 COG7 INPP5K CLPTM1

5.35e-0428346421903422
Pubmed

Novel interactors and a role for supervillin in early cytokinesis.

ATRX PCNX3

6.33e-042846220309963
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

LRRC8A SPG11 ANKH GPR107 NAT10

6.55e-0452946514621295
Pubmed

The human and mouse repertoire of the adhesion family of G-protein-coupled receptors.

ADGRE2 ADGRE3

6.79e-042946215203201
Pubmed

Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2.

EGLN3 IQGAP2

6.79e-042946216966370
Pubmed

New genetic associations detected in a host response study to hepatitis B vaccine.

CCL19 ADGRE2 CD96 ADGRE3 CX3CR1 SYNE2

7.25e-0482446620237496
Pubmed

International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.

ADGRE2 ADGRE3

8.80e-043346225713288
Pubmed

Expression profiles and pathway analysis in HEK 293 T cells overexpressing HIV-1 Tat and nucleocapsid using cDNA microarray.

CSE1L CX3CR1

1.29e-034046218051367
Cytoband16p12.2

VWA3A COG7

6.68e-043747216p12.2
Cytoband19p13.1

ADGRE2 ADGRE3

1.12e-034847219p13.1
Cytoband9q34.11

LRRC8A GPR107

1.37e-03534729q34.11
CytobandEnsembl 112 genes in cytogenetic band chr14q13

EGLN3 PRORP

1.75e-0360472chr14q13
GeneFamilyCD molecules|Adhesion G protein-coupled receptors, subfamily E

ADGRE2 ADGRE3

2.65e-055302915
ToppCell3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

P2RY8 ADPRH ADGRE2 ADGRE3 CX3CR1

1.13e-06179465ce95b601bf17ae8167d382a105384b9e65e9407f
ToppCellCOPD-Lymphoid-NK|COPD / Disease state, Lineage and Cell class

P2RY8 IQGAP2 CD96 CX3CR1 SYNE2

1.44e-06188465c9a227c8e71b69929d43e9afb8306a95c8163778
ToppCellCOPD-Lymphoid-NK|World / Disease state, Lineage and Cell class

P2RY8 IQGAP2 CD96 CX3CR1 SYNE2

1.48e-06189465c0ac160fa7e68b92414fb1600abcac8ad1a42232
ToppCellIPF-Lymphoid-NK|IPF / Disease state, Lineage and Cell class

P2RY8 IQGAP2 CD96 CX3CR1 SYNE2

1.48e-06189465d92e880162450f8d01e4b8784eb625275cb8e03e
ToppCellCOVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations)

P2RY8 IQGAP2 CD96 CX3CR1 SYNE2

1.48e-06189465b699152dfbb8cd8ed724e1e5a51838f29b681b62
ToppCellAdult-Immune-natural_killer_cell|Adult / Lineage, Cell type, age group and donor

P2RY8 IQGAP2 CD96 CX3CR1 SYNE2

1.56e-06191465758ec27e47d7662a5175305e98a1506c6859dbf7
ToppCellIPF-Lymphoid-NK|World / Disease state, Lineage and Cell class

P2RY8 IQGAP2 CD96 CX3CR1 SYNE2

1.56e-06191465f206159b9d5e84cf14a65bfdc008895cec5a8081
ToppCellCOVID-19-lung-NK_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type

P2RY8 IQGAP2 CD96 CX3CR1 SYNE2

1.68e-061944654c92f18e0a34fb50630d4b260eaf179202508b6d
ToppCellCOVID-19-lung-NK_cells|lung / Disease (COVID-19 only), tissue and cell type

P2RY8 IQGAP2 CD96 CX3CR1 SYNE2

1.72e-061954653b716ec7acc9a37af6bf40e711a539ce58d74aa4
ToppCellCOVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

P2RY8 SPG11 CD96 CX3CR1 SYNE2

1.81e-06197465836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCellT_cells-CTLs|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis

P2RY8 SPG11 ADGRE2 CX3CR1 SYNE2

1.81e-0619746528117cf300e169182571fbad0de1681a484a435a
ToppCellT_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis

P2RY8 ADGRE2 IQGAP2 CX3CR1 SYNE2

1.81e-061974652de34e20915a247bee75aa40495e23c20bb23e18
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

P2RY8 IQGAP2 CD96 CX3CR1 SYNE2

1.86e-061984659ce9b3721fb8a154667211c29e60133412134c76
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

P2RY8 IQGAP2 CD96 CX3CR1 SYNE2

1.86e-061984653c23fb8a84d4e4a20f7fa60055c7b37fc45a29d5
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

P2RY8 PRORP IQGAP2 CD96 CX3CR1

1.90e-061994657d69785717073491b5fb81bf24db0175f86cd0b0
ToppCellMS-Multiple_Sclerosis-Lymphocyte-T/NK-ILC|Multiple_Sclerosis / Disease, condition lineage and cell class

P2RY8 EGLN3 PSEN2 RNF31 CD96

1.95e-06200465ab9bdc9365cbdffe4ed246ce0c8a008a390e387e
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

EGLN3 KCNC2 SYTL5 MTNR1A

1.36e-05141464ad9a25569c142fb68ded34aeba0cd9be8124ce56
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

P2RY8 IQGAP2 CD96 SYNE2

2.08e-05157464170197b76620df31495f1247f365da382b2d8045
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

P2RY8 IQGAP2 CD96 SYNE2

2.08e-05157464c21520301cc0d5d4b1cc4b8ec735f9adb698e768
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

P2RY8 IQGAP2 CD96 SYNE2

2.13e-051584647274f020c0ecf216da4b6689c62bc5f49c29b6f3
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

P2RY8 IQGAP2 CD96 CX3CR1

2.71e-05168464318fa1bd5a9d6ae95042517ef30515b6416b61e4
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

P2RY8 IQGAP2 CD96 CX3CR1

2.71e-0516846475b3998aff704a77895ee3723813d8a3819b7cec
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

P2RY8 IQGAP2 CD96 SYNE2

2.90e-05171464e1fe07652c10c37191d1471ddaea500f74269e0c
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

IQGAP2 CD96 CX3CR1 SYNE2

3.25e-051764645914e7635474e7cf24d446bdb1423bc0807ee9c6
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ADGRE2 SLF2 CX3CR1 SYNE2

3.32e-05177464d3e6c768b88b7906f3c7fdd00ba20842212c14b1
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ADGRE2 SLF2 CX3CR1 SYNE2

3.32e-05177464f8f101c772c043636bedd6b2ec81409b1d2599bf
ToppCellBAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_Exhausted-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

P2RY8 ANKH CD96 SYNE2

3.32e-0517746428f2ea29a52de90301e6ba770f407ee4034936d5
ToppCellCOVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class

ADGRE2 SLF2 CX3CR1 SYNE2

3.32e-051774646978a22fef40c8b455342373abe7593f5ede0fa4
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

ADGRE2 SLF2 CX3CR1 SYNE2

3.32e-05177464936ab2b180a052387124f68d0c7f41c0b164e748
ToppCellPBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ADGRE2 SLF2 CX3CR1 SYNE2

3.32e-05177464d5aeda113afaa2425874394610344570c9078478
ToppCellBAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_Exhausted|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

P2RY8 ANKH CD96 SYNE2

3.32e-05177464f87bbc9403e909bb534eb705bcd2bca83d072cc7
ToppCellAdult-Immune-natural_killer_cell-D175|Adult / Lineage, Cell type, age group and donor

P2RY8 IQGAP2 CD96 SYNE2

3.55e-05180464fc59e28f39e7d4fb1bcc7205202cf39224b70d7b
ToppCellfacs-Spleen-nan-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PDE2A IQGAP2 CD96 CX3CR1

3.55e-05180464407fd8f61a757626e082b6e2eefd3a33276e6b71
ToppCellCOVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type

P2RY8 IQGAP2 CD96 CX3CR1

3.62e-051814648906ee8a7a1616dfe8c3b5c73988416641213629
ToppCellAdult-Immune-natural_killer_cell-D231|Adult / Lineage, Cell type, age group and donor

P2RY8 IQGAP2 CD96 CX3CR1

3.70e-05182464dbf47bf4754d8ec3bc3ab1d5be7a6c47a7afbf43
ToppCellfacs-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRRC8A PDE2A FBH1 CX3CR1

3.70e-051824644c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf
ToppCellCOVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class

FBH1 ADGRE2 SLF2 CX3CR1

3.78e-0518346422bd05135906d0ecc4ba8c2e0a666093d1bf3b8f
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

P2RY8 IQGAP2 CD96 CX3CR1

3.95e-0518546445890fa81c65a48f4fdec164a4c8d0e2831243c0
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

P2RY8 IQGAP2 CD96 CX3CR1

3.95e-05185464585bcfdff85bf43f5aa4cd1b39f7dcf1c78d7b02
ToppCellControl-T_cells-NK_cells|Control / group, cell type (main and fine annotations)

P2RY8 IQGAP2 CD96 CX3CR1

3.95e-05185464755c0998c729f462399f1d5e88adf4bfae31be30
ToppCellControl-T_cells|Control / group, cell type (main and fine annotations)

P2RY8 IQGAP2 CD96 SYNE2

4.11e-05187464f4e8e0eba58da89b56587667555a5d4754e108c7
ToppCellSmart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

IQGAP2 CD96 CX3CR1 SYNE2

4.11e-051874646981b856187a2e689260ecb7d0a1193a374ee9b9
ToppCellChildren_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

P2RY8 IQGAP2 CD96 SYNE2

4.29e-05189464df30478b288084a1bd48f660409dcc784040897c
ToppCellCOVID-19-T_cells-CD8+_T_cells|COVID-19 / group, cell type (main and fine annotations)

P2RY8 IQGAP2 CD96 SYNE2

4.29e-051894642c018d6120f65f0b2704b483bc9da1c0984872e3
ToppCellControl-Lymphoid-NK|World / Disease state, Lineage and Cell class

P2RY8 CD96 CX3CR1 SYNE2

4.29e-0518946489ef0d0e66dc96cacaae6be7aacdaa884e8e66a8
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

P2RY8 IQGAP2 CD96 CX3CR1

4.38e-051904644a75457652d85874d5c6a41648f8003572008b15
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

P2RY8 IQGAP2 CD96 SYNE2

4.38e-0519046491ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

P2RY8 CD96 CX3CR1 SYNE2

4.38e-05190464d153a0bdedcd6865e6ee19575234a78b5d859ff1
ToppCellIPF-Lymphoid-T_Cytotoxic|IPF / Disease state, Lineage and Cell class

P2RY8 IQGAP2 CD96 SYNE2

4.38e-05190464e5d0186bfb416a3eda76ac12b9379650afb6f409
ToppCellIPF-Lymphoid-T|IPF / Disease state, Lineage and Cell class

P2RY8 IQGAP2 CD96 SYNE2

4.38e-05190464d57df208aaf7a5554899bb9107c80b443fd0cf93
ToppCellControl-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations)

P2RY8 IQGAP2 CD96 SYNE2

4.38e-051904640733be5e54fe15d6d6ea51c154a95258e83f1b92
ToppCellCOVID-19-kidney-NK|kidney / Disease (COVID-19 only), tissue and cell type

P2RY8 IQGAP2 CD96 CX3CR1

4.38e-05190464e3ca3c9fb9e27670a5dd128dd6564ff98a57159e
ToppCellASK428-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq

LRRC8A CD96 CX3CR1 SYNE2

4.38e-05190464d649f7e17c4227787465dfc02037f791ff85378b
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

P2RY8 IQGAP2 CD96 CX3CR1

4.38e-05190464cda6173634531240e0bab8766231a150ff8d0129
ToppCellControl-Lymphoid-NK|Control / Disease state, Lineage and Cell class

P2RY8 CD96 CX3CR1 SYNE2

4.38e-05190464f7bd8521a40ac30a64dc439f17e2f6c7d021ef65
ToppCellAdult-Immune-T_lymphocyte-D175|Adult / Lineage, Cell type, age group and donor

P2RY8 IQGAP2 CD96 SYNE2

4.47e-051914640b84fd1dc68146d9f72422b102744d2847f5ecb2
ToppCellChildren_(3_yrs)-Immune-natural_killer_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

P2RY8 IQGAP2 CD96 CX3CR1

4.47e-051914649b8b64a36e27a2523b8730c7922fd7ad865a021e
ToppCellCOVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations)

P2RY8 IQGAP2 CD96 SYNE2

4.47e-051914640646cca78e24aeb6baa9934d3c439b797c567997
ToppCellCOVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations)

P2RY8 IQGAP2 CD96 SYNE2

4.47e-051914647f64add931b64b8d35836fa6bee9ebab593844d3
ToppCellCOPD-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class

P2RY8 IQGAP2 CD96 SYNE2

4.56e-051924645bfd9f5d47511441eb2d3cc3c4d7ed330ffd0bd1
ToppCellCOPD-Lymphoid|COPD / Disease state, Lineage and Cell class

P2RY8 IQGAP2 CD96 SYNE2

4.56e-05192464064fefb8212fadab0ff441f4bf643559b7fdb25d
ToppCellImmune-natural_killer_cell|World / Lineage, Cell type, age group and donor

P2RY8 IQGAP2 CD96 CX3CR1

4.56e-0519246468121a6ef4115a93d87aad8802ef9b27d793d8c0
ToppCellnucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

P2RY8 IQGAP2 CD96 CX3CR1

4.56e-05192464a06d5d3c2537f8d2b1dc6b6f3e88a80b5c2a1850
ToppCellCOPD-Lymphoid-T_Cytotoxic|COPD / Disease state, Lineage and Cell class

P2RY8 IQGAP2 CD96 SYNE2

4.65e-0519346458e94fe2e89cdafc6974938f97a4c162061a437d
ToppCellLAM-Lymphoid|LAM / Condition, Lineage and Cell class

P2RY8 MEI1 CD96 CX3CR1

4.65e-051934649495134779bce4997f8b21d8921bfd5af17f050b
ToppCellAdult-Immune-T_lymphocyte|Adult / Lineage, Cell type, age group and donor

P2RY8 IQGAP2 CD96 SYNE2

4.65e-0519346426df0c4c8a2355dd5503fadd07e368eb9a2bf06a
ToppCellIPF-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class

P2RY8 IQGAP2 CD96 SYNE2

4.65e-0519346435c902a983d7f1156a74fe68ee366609029833b3
ToppCellnormal_Lymph_Node-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass

P2RY8 CCL19 PSEN2 CLPTM1

4.65e-05193464024d30eb143d8278c0851c3a6c9426226fa3b480
ToppCellBAL-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

EGLN3 PDE2A ADGRE2 CX3CR1

4.65e-05193464704378de39e1b6f108ab5b0ecbd594d414ec8ae4
ToppCellChildren_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor

P2RY8 IQGAP2 CD96 SYNE2

4.65e-05193464b9769b45125d2244afe53f9f71c92c04ddccf980
ToppCellCOVID-19-lung-NK/NKT|COVID-19 / Disease (COVID-19 only), tissue and cell type

P2RY8 IQGAP2 CD96 CX3CR1

4.65e-05193464c24b44fcc92fff42ebba6f1aff91c7aaea179e56
ToppCellmetastatic_Lymph_Node-T/NK_cells-CD8_low_T|metastatic_Lymph_Node / Location, Cell class and cell subclass

P2RY8 CD96 CX3CR1 SYNE2

4.75e-05194464b0595b98332fee7936e455240bbefe72b79c98b8
ToppCellChildren_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

P2RY8 IQGAP2 CD96 SYNE2

4.75e-051944643d6f2d190dd50804afea299957cc44c2bb756134
ToppCellAdult-Immune-T_lymphocyte-D231|Adult / Lineage, Cell type, age group and donor

P2RY8 IQGAP2 CD96 SYNE2

4.75e-051944645c1dca33f382f37a7deb23e573578343c3b54986
ToppCellCOVID-19-lung-CD4+_T_cells_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type

P2RY8 IQGAP2 CD96 SYNE2

4.75e-051944642a144a1c2d537c8a59aa419206ddd96c23f0aeab
ToppCell3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

P2RY8 IQGAP2 CD96 CX3CR1

4.84e-05195464e1b7ef4ba2ab14d3c839b6305d91efcfd0826220
ToppCell3'-Distal_airway-Immune_Lymphocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

P2RY8 IQGAP2 CD96 CX3CR1

4.84e-051954644a60b51f92830882872f2fe1a911db2970faf071
ToppCellnucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

P2RY8 IQGAP2 CD96 SYNE2

4.84e-05195464ffb40486f8097b2c08e8f3b3685d0b8cb8d1bc66
ToppCellnucseq-Immune-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

P2RY8 IQGAP2 CD96 SYNE2

4.84e-05195464b8124e8a23e6d37b40023608674e67285c6ffe84
ToppCellCOVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters

P2RY8 ADGRE2 SYNE2 NAT10

4.84e-05195464bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

P2RY8 IQGAP2 CD96 SYNE2

4.84e-0519546436c784709ee32174e05b457500339c3b8eee3244
ToppCellCOVID-19-lung-NK/NKT|lung / Disease (COVID-19 only), tissue and cell type

P2RY8 IQGAP2 CD96 CX3CR1

4.84e-051954643ab941a369e3815f338890b116dc77aefa054098
ToppCell5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

P2RY8 ADGRE2 ADGRE3 CX3CR1

4.84e-0519546497a9410f47beca02346902d078288a75bfe6e56b
ToppCellCOVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class

ADGRE2 CD96 CX3CR1 SYNE2

4.84e-051954649990440bda7fac5d00ef80444fab07459be625e1
ToppCellLAM-Lymphoid-NK|LAM / Condition, Lineage and Cell class

P2RY8 CD96 CX3CR1 SYNE2

4.84e-05195464229374c72acef32b0e915379bdf3c82f351940e2
ToppCellhealthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass

P2RY8 CD96 CX3CR1 SYNE2

4.94e-05196464af00c31612e4fe068e5fccae05368edba46bbd20
ToppCellT_cells-GZMK+_T_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

ADGRE2 IQGAP2 CD96 SYNE2

4.94e-05196464fa5c7fec9e0dcd7e62ff64704bfdf2a3437a43ba
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

ADGRE2 CD96 CX3CR1 SYNE2

4.94e-05196464418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ADGRE2 CD96 CX3CR1 SYNE2

4.94e-05196464581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

P2RY8 CD96 CX3CR1 SYNE2

4.94e-051964640f3c7fd450aaa1f866b8558692534c0ea2a34e75
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

P2RY8 CD96 CX3CR1 SYNE2

4.94e-051964644e1f8828413896ab8a4ec92a89d6789e8e37e05a
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ADGRE2 CD96 CX3CR1 SYNE2

4.94e-051964646beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ADGRE2 CD96 CX3CR1 SYNE2

4.94e-05196464c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

P2RY8 CD96 CX3CR1 SYNE2

5.04e-051974642b3a56bb1d40bc1284a5931c4e7b373660de5402
ToppCellCOVID-19_Severe-Lymphoid_T/NK-CD8+_Tem|COVID-19_Severe / Disease group, lineage and cell class

P2RY8 CD96 CX3CR1 SYNE2

5.04e-05197464f0bac4d5c3160933ac3786cec8dadffb35d711ea
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

P2RY8 CD96 CX3CR1 SYNE2

5.04e-05197464f73ece3aca28c0db5db0f12e026d42c6c36b9efb
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

P2RY8 CD96 CX3CR1 SYNE2

5.04e-05197464e70e7d97823a762def3970d94a0e897981a6c922
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

P2RY8 ADGRE2 IQGAP2 CD96

5.04e-05197464c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

P2RY8 CD96 CX3CR1 SYNE2

5.04e-05197464bce0135a96910d2bace62a3408a1a6fdac0cf0df
ToppCellsevere_COVID-19-CD4+_CTL|severe_COVID-19 / disease group, cell group and cell class (v2)

P2RY8 CD96 CX3CR1 SYNE2

5.04e-05197464e51b7cd03b1450dc8601b4be0453b104d6a5f955
Diseaseage-related hearing impairment

EGLN3 DGLUCY CD96 PIWIL1

1.49e-03324454EFO_0005782

Protein segments in the cluster

PeptideGeneStartEntry
LAYYYKCHKVQLLAA

COG7

221

P83436
HVCLYGNIRLAYVYL

ACCS

201

Q96QU6
KVLCSIIAGTLHYLY

ADGRE2

596

Q9UHX3
RRYLYHLYGKCLAVL

CX3CR1

301

P49238
LKYTIKCVALAIYYH

CCNY

116

Q8ND76
LVLYCGSRLGKYYVK

EGLN3

101

Q9H6Z9
LKLFRHYYVLIVCYI

GPR107

491

Q5VW38
LCKIKYYNYCLIHNV

PPIL4

31

Q8WUA2
YYHVYKLTLCLSCLN

P2RY8

271

Q86VZ1
ILIICYTVYYVHNIK

LRRC8A

276

Q8IWT6
FAYVLNYYRTGKLHC

KCNC2

111

Q96PR1
YIVRNFHYLLIKDGC

CCL19

41

Q99731
KLYAGLQCVEKYLIY

PCNX3

1136

Q9H6A9
VLVATYGQELLCYKY

KPTN

326

Q9Y664
HFCYLLYKNLELTNY

PDE2A

666

O00408
NIRYCYYNETHKILG

NAT10

101

Q9H0A0
QYCILLLFYLAYIHE

MEI1

691

Q5TIA1
SIQCKLYQYYLDHLT

ATRX

1841

P46100
ISNRIHYNIFYCLYL

FBH1

401

Q8NFZ0
GVNICLKLYGYYVSI

INPP5K

131

Q9BT40
LKLYGYYVSIINCHL

INPP5K

136

Q9BT40
TTLCLGYYKNIHDII

ANKH

206

Q9HCJ1
YILYSCAVHSQYLRK

DGLUCY

531

Q7Z3D6
HLFCLYLVSKYLGVS

CPT1B

656

Q92523
DHIQRLTYKLCHIYY

PIWIL1

806

Q96J94
LLHISYCYKTGGLYI

SYTL5

411

Q8TDW5
LLEFHYYKCLVLGLV

SYNE2

481

Q8WXH0
YCIHKNIYMGLLIYA

TMEM217B

76

A0A494BZU4
IYCIHALSLYLFKLG

IQGAP2

146

Q13576
CFYVYGARLYCLKIH

PIGQ

401

Q9BRB3
KDFHYLYFAILLCGL

SLC5A9

526

Q2M3M2
SKYYCLAAVAALLKY

MSH4

271

O15457
LEKQAYYLTYILLHL

SLF2

1081

Q8IX21
GIVSYDLLVKYLYLC

PRORP

171

O15091
KVLCSIIAGALHYLY

ADGRE3

416

Q9BY15
LTQLYYLLAKHYQDC

ADPRH

76

P54922
LLGCYAVYSLLYLEH

CLPTM1

486

O96005
YYRQHCTLELGSYIK

CTDNEP1

156

O95476
GLCQAHYKEYLVSLI

RNF31

996

Q96EP0
LQHLLYVYLDCYKLS

SPG11

1001

Q96JI7
CYLLLYTYLIGEKQH

VIL1

426

P09327
LVFINLYCIKYGALA

CSE1L

791

P55060
KYCAVYYIIQIHFVK

CD96

6

P40200
YHYHKSYLILCGITN

SLC16A4

366

O15374
LVVLYKYRCYKFIHG

PSEN2

156

P49810
LKNLAEAVRGYYHCY

VWA3A

311

A6NCI4
IAINRYCYICHSLKY

MTNR1A

121

P48039
FKYLHYYLTSAIQLL

ART4

156

Q93070